Clinician's Roundtable

ReachMD

Tune in to interviews with the top thought leaders in medicine exploring the clinical and professional issues that are foremost in the minds of the medical community. Join us at the Clinician's Roundtable for discussions on a vast range of topics that every medical professional should know about.

Play

Open in

33 episodes
Avg 8 min
English

Episodes 33

Newest Oldest Longest

All20 Unplayed20 In progress0 Played0

Counted on this page — what you have heard stays on this device, so it is not something the list can be paged by.

Friday · 3 min
Understanding the Burden of Mucus Plugging in Patients with COPD
Guest: Emily Wan, MD, MPH Mucus plugging is increasingly recognized as an important radiographic biomarker in patients with COPD, but what does its presence mean for clinical outcomes? Joining us to share insights from her presentation at the 2026 GOLD International COPD Conference is Dr. Emily Wan. She discusses the high prevalence of CT-detected mucus plugs, their distinction from symptomatic chronic bronchitis, and their associations with lung function decline, acute exacerbations, and increased all-cause mortality. Dr. Wan is the Section Chief of Pulmonary and Critical Care at the Minneapolis VA Health Care System and an Associate Professor of Medicine at the University of Minnesota.
Friday · 4 min
Exploring Metabolic Biomarkers for Earlier Detection and Treatment of DKD
Guest: Kumar Sharma, MD, FAHA, FASN What if we could identify diabetic kidney disease (DKD) before traditional markers reveal kidney damage? Dr. Kumar Sharma joins us to explore how emerging blood and urine biomarkers may help identify these underlying changes, improve disease staging, and guide future therapeutic strategies that build on the kidney-protective benefits of SGLT2 inhibitors. He's the Chief of the Division of Nephrology and Vice Chair for Research in the Department of Medicine at UT Health San Antonio.
Friday · 5 min
Exploring Drivers of DKD: Metabolic Rewiring and Mitochondrial Dysfunction
Guest: Kumar Sharma, MD, FAHA, FASN Metabolic changes in the diabetic kidney can set off a cascade of cellular dysfunction, inflammation, and fibrosis that contributes to kidney damage. Join Dr. Kumar Sharma, Chief of the Division of Nephrology and Vice Chair for Research in the Department of Medicine at UT Health San Antonio, as he explains how metabolic rewiring, mitochondrial dysfunction, and excess adenine production contribute to the progression of diabetic kidney disease (DKD).
Friday · 4 min
Metabolic Rewiring in DKD: The Role of Tubular Cells
Guest: Kumar Sharma, MD, FAHA, FASN How does altered glucose metabolism contribute to kidney damage in patients with diabetes? Join Dr. Kumar Sharma, Chief of the Division of Nephrology and Vice Chair for Research in the Department of Medicine at UT Health San Antonio, as he explores the metabolic shift from fatty acid oxidation to glycolysis in proximal tubular cells, examining how excess glucose drives lactate production and disrupts mitochondrial function. Learn how emerging findings from patient kidney biopsies are advancing our understanding of metabolic dysfunction in diabetic kidney disease (DKD).
November 3 · 14 min
A Patient-Centered Approach to Obesity Management
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Ted Kyle Effective obesity care starts with recognizing the complexity of the condition and the impacts of weight bias and stigma on patient care. Joining Dr. Peter Buch to discuss the evolving role of GLP-1–based therapies and explore how shared decision-making can help clinicians engage patients as active partners in long-term obesity care is Ted Kyle. He's the Founder of ConscienHealth, Policy and Advocacy Advisor to the Obesity Society, and Past Chair of the Obesity Action Coalition.
November 2 · 2 min
The Emerging Role of Triple Agonists in Obesity Management
Guest: Javier Morales, MD, FACP, FACE The role of triple agonist therapies in obesity and type 2 diabetes management is evolving. Hear from Dr. Javier Morales as he explains how these therapies work and what these advances may mean for individualized treatment strategies. Dr. Morales is an Associate Clinical Professor of Medicine at the Barbara and Donald Zucker School of Medicine at Hofstra University and Northwell.
October 20 · 10 min
PPV vs Phacovitrectomy for RRD in Phakic Eyes
Host: Vaidehi S. Dedania, MD Guest: Yewlin E. Chee, MD Guest: Joshua H. Uhr, MD Does phacovitrectomy improve outcomes over conventional PPV for rhegmatogenous retinal detachment repair in a phakic eyes? Or does it introduce unnecessary complexity? Vaidehi Dedania, MD; Yewlin Chee, MD; and Joshua Uhr, MD, review results from a multicenter cohort study published in Ophthalmology Retina and discuss whether the study's findings have any bearing on real-world decision-making, parse generational differences regarding perceived phacovitrectomy risks, and review whether changes to technology during the course of the study may have affected the findings.
October 13 · 13 min
Personalized CRC Screening: Applying Real-World Evidence to Test Selection
Host: Brian P. McDonough, MD, FAAFP Guest: David A. Johnson, MD, FACG, FACP Individualizing colorectal cancer screening isn't just about picking the "best" test; it's about picking the one your patient will actually complete. From weighing risk and preference to anticipating barriers with follow-up care, real-world adherence patterns can help providers guide patients toward the right screening pathway. Joining Dr. Brian McDonough to discuss how clinicians can personalize colorectal cancer screening recommendations to improve long-term adherence is Dr. David Johnson, Professor of Medicine and Chief of Gastroenterology at Eastern Virginia Medical School at Old Dominion University.
October 7 · 7 min
Can Metformin Use Cut Wet AMD Risk?
Host: Maria Berrocal Guest: Dimitra Skondra, MD Could metformin reduce risk of wet AMD development? Maria Berrocal, MD, speaks with Dimitra Skondra, MD, PhD, about a study published in Ophthalmology Retina finding that metformin exposure was associated with up to 30% lower odds of new-onset wet AMD. They discuss what the findings mean for patients with and without diabetes, where the protective effect appears to break down, and what a prospective trial could tell us next.
October 5 · 10 min
Managing Anticoagulation Reversal Before Orthopedic and Trauma Fracture Surgery
Host: Charles Turck, PharmD, BCPS, BCCCP Guest: John A. Scolaro, MD MA For anticoagulated patients with orthopedic or trauma fractures, delaying surgery to reduce bleeding risk may carry its own consequences. Join Dr. Charles Turck and Dr. John Scolaro as they explore how factors like surgical approaches, anticoagulation indications, comorbidities, transfusion-related risks, and physiologic reserve inform reversal decisions and discuss why multidisciplinary communication and timely intervention are critical throughout perioperative care and rehabilitation. Dr. Scolaro is an Associate Professor, Residency Program Director, and Chief of Orthopedic Trauma in the Department of Orthopedic Surgery at the University of California, Irvine.
October 1 · 3 min
Navigating Vaccine Hesitancy: Practical Conversation Strategies for Primary Care
Guest: Darilyn Moyer, MD, MACP, FRCP, FIDSA, FAMWA, FEFIM With vaccination rates at historic lows and trust in public health institutions declining, primary care clinicians remain one of the most trusted sources of guidance for patients. Hear from Dr. Darilyn Moyer, Executive Vice President and Chief Executive Officer of the American College of Physicians, as she shares strategies for navigating difficult conversations about vaccines and preventive care.
September 23 · 13 min
Vitreous Hemorrhage Following PVD: Who Needs Surgery?
Host: Barton Lynn Blackorby, MD Guest: Kyle Davis Kovacs, MD Guest: Matthew Starr, MD How aggressively should you manage a vitreous hemorrhage after a PVD when you can't see the retina underneath it? Barton Blackorby, MD, moderates a discussion with Matt Starr, MD, and Kyle Kovacs, MD, about a study published in Ophthalmology by Hasbolat et al examining 366 patients with PVD-related vitreous hemorrhage initially managed with observation. The panel discusses how exam technique and B-scan reliance may affect detachment detection rates, debates follow-up intervals given that most retinal detachments in the study occurred within the first 3 weeks, and shares their own thresholds for moving to early vitrectomy versus continued observation, including how they counsel patients eager for faster visual recovery.
September 3 · 6 min
Does Preoperative Anti-VEGF Change Outcomes in Non-Tractional Vitreous Hemorrhage?
Host: Maria Berrocal Guest: Sumit Sharma, MD What happens when vitreous hemorrhage (VH) secondary to non-tractional PDR doesn't clear on its own? And does preoperative anti-VEGF actually change surgical outcomes? Maria Berrocal, MD, speaks with Sumit Sharma, MD, about a retrospective case series of 360 patients who underwent vitrectomy for non-clearing VH without tractional elements, examining whether preoperative anti-VEGF injection affects the risk of postoperative rebleeding, when to consider repeat vitrectomy, and how both physicians approach these cases in their own practices.
August 31 · 14 min
Closing Gaps in CRC Screening: From Stool-Based Testing to Timely Colonoscopy
Host: Shelina Ramnarine, PhD Guest: David A. Johnson, MD, FACG, FACP Noninvasive colorectal cancer screening is only effective when abnormal results lead to timely, high-quality colonoscopy, but recent data shows significant gaps in follow-up. Join Dr. Shelina Ramnarine and Dr. David Johnson, Chief of Gastroenterology at Eastern Virginia Medical School at Old Dominion University, as they explore how primary acre clinicians can set expectations with patients, address barriers to follow-up, and strengthen workflows and care coordination to close the loop.
August 31 · 13 min
Closing the Colonoscopy Follow-Up Gap: Insights from a JNCCN Study
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Mallik Greene, PhD Guest: Jordan Karlitz, MD A study published in the Journal of the National Comprehensive Cancer Network examined follow-up colonoscopy rates after positive stool-based colorectal cancer screening tests, finding notably higher and faster completion rates with multi-target stool DNA testing compared to fecal immunochemical testing. These findings highlight the critical role of patient navigation in closing follow-up gaps and reducing disparities across racial and ethnic groups. Joining Dr. Peter Buch to discuss their research and its implications for everyday practice are Dr. Mallik Greene and Dr. Jordan Karlitz. Dr. Greene is a health economics and outcome research expert at Abbott Cancer Diagnostics, and Dr. Karlitz is a volunteer gastroenterology professor at the University of Colorado School of Medicine and a Senior Medical Officer at Abbott Cancer Diagnostics. Read the JNCCN study: Multitarget Stool DNA Versus Fecal Immunochemical Testing: A National Assessment of Follow-Up Colonoscopy by Race and Ethnicity
August 17 · 14 min
Improving Long-Term Adherence to CRC Screening Recommendations
Host: Brian P. McDonough, MD, FAAFP Guest: David A. Lieberman, MD Long-term effectiveness of colorectal cancer (CRC) screening depends on more than the performance of an individual test; it requires sustained adherence to recommended screening intervals and timely follow-up after abnormal results. But real-world data shows that many patients fall off track over time. Learn more about how we can improve adherence, reduce disparities, and strengthen continuity across the screening pathway as Dr. Brian McDonough sits down with Dr. David Lieberman, Professor Emeritus in the Department of Medicine and former Chief of the Division of Gastroenterology and Hepatology at Oregon Health & Science University in Portland.
August 13 · 14 min
Improving IV Medication Accuracy with Smart Pump Safety Procedures
Host: Shelina Ramnarine, PhD Guest: Samuel Ubanyionwu, PharmD, EMBA Accurate IV medication delivery depends on more than proper pump programming alone. It requires a comprehensive understanding of smart pump drug libraries, dose error reduction software (DERS), infusion mechanics, and system-level safety procedures. To explore how these elements work together to support IV medication accuracy, patient safety, and clinical decision-making, Dr. Shelina Ramnarine speaks with Dr. Samuel Ubanyionwu, Medication Management Informaticist in Pharmacy Services and an Assistant Professor of Pharmacy at the Mayo Clinic College of Medicine.
July 30 · 3 min
Helping Patients with IgAN Navigate Treatment Decisions
Guest: Sayna Norouzi, MD Because patients with IgA nephropathy (IgAN) often have few symptoms early in the disease course, communicating the importance of treatment and its impacts on long-term outcomes can be challenging. Join Dr. Sayna Norouzi as she discusses practical communication techniques for explaining prognosis, setting expectations around therapy, and partnering with patients to support informed treatment decisions and long-term kidney health. Dr. Norouzi is an Associate Professor of Medicine and Clinical Nephrologist at Loma Linda University Medical Center in California. She's also the Founder and Director of the Glomerular Diseases Clinic at Loma Linda and Director of the GlomCon Glomerular Diseases Fellowship Program.
July 23 · 2 min
Seeking Expert Opinions in IgAN Care
Guest: Anjay Rastogi, MD, PhD Managing IgA nephropathy (IgAN) is becoming increasingly complex. In this episode, Dr. Anjay Rastogi explains why an expert opinion—not simply a second opinion—can help clinicians confirm diagnoses, optimize treatment decisions, and connect appropriate patients with specialized care and emerging therapeutic opportunities. Dr. Rastogi is a Professor of Medicine and Clinical Chief of Nephrology at the David Geffen School of Medicine at UCLA. He's also the Director of the UCLA CORE Kidney Health Program.
July 23 · 2 min
The Pathologist’s Role in IgAN Management
Guest: Anjay Rastogi, MD, PhD Closer collaboration between nephrologists and pathologists is essential for optimizing the diagnosis and management of IgA nephropathy (IgAN). Hear from Dr. Anjay Rastogi as he highlights how pathology insights, clinical context, and ongoing communication can improve interpretation of kidney biopsy findings and support more informed treatment decisions. He's a Professor of Medicine and Clinical Chief of Nephrology at the David Geffen School of Medicine at UCLA, as well as the Director of the UCLA CORE Kidney Health Program.

Showing 1–20 of 33 episodes